welcometo»¶Ó­¹âÁٱط¢¼¯ÍÅ

Öйú¡¤±Ø·¢¼¯ÍÅ(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾ Öйú¡¤±Ø·¢¼¯ÍÅ(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾

License out£¡welcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÒ½Ò©ÊÚȨSELLAS Life SciencesÐÂÒ»´ú¸ßÑ¡ÔñÐÔµÄCDK9ÒÖÖÆ¼Á

Öйú¡¤±Ø·¢¼¯ÍÅ(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
ҽҩħ·½
Öйú¡¤±Ø·¢¼¯ÍÅ(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
2022-04-01
·ÖÏíµ½
Öйú¡¤±Ø·¢¼¯ÍÅ(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾
Öйú¡¤±Ø·¢¼¯ÍÅ(¹É·Ý)ÓÐÏÞ¹«Ë¾-¹Ù·½ÍøÕ¾

welcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÒ½Ò©ÓëÃÀ¹úÉÏÊй«Ë¾SELLASÉúÃü¿ÆÑ§¼¯ÍÅÐû¹«¸æ¿¢ºÏ×÷ЭÒ飺SELLAS½«Ïòwelcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÖ§¸¶1,000ÍòÃÀÔªÊ׸¶¿î¡¢ÒÔ¼°²»Áè¼Ý1.4ÒÚÃÀÔªµÄ¿ª·¢¼°ÏúÊÛÀï³Ì±®¸¶¿î £¬»ñµÃwelcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÒ½Ò©¸ßÑ¡ÔñÐÔCDK9ÒÖÖÆ¼ÁGFH009ÔÚ´óÖлªÇø£¨°üÀ¨Öйú´ó½¡¢Ïã¸Û¡¢°ÄÃÅ¡¢Ì¨Í壩֮ÍâµÄÈ«Çò¿ª·¢ºÍÉÌÒµ»¯È¨Ò棻 SELLAS»¹½«»ùÓÚGFH009µÄÄê¶È¾»ÏúÊÛ¶î°Ù·Ö±È £¬Ïòwelcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÖ§¸¶ÌݶÈÌØÐíȨʹÓ÷Ñ¡£ 

ÏÖÔÚwelcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÒÑÔÚÖÐÃÀÁ½µØ¿ªÕ¹GFH009Õë¶Ô¸´·¢ÐÔ/ÄÑÖÎÐÔ¶ñÐÔѪҺÁö»¼ÕßµÄIÆÚÁÙ´²ÊÔÑé¡£»ùÓÚIÆÚ¼ÁÁ¿ÅÀÆÂÊÔÑéÆðÔ´Ò©´ú¶¯Á¦Ñ§Êý¾Ý £¬SELLASÏàÐÅºÍÆäËûͬÀàÐÍÁÙ´²Ñо¿½×¶Î²úÆ·Ïà±È £¬GFH009¶ÔCDK9ÂѰ׵ĸßÑ¡ÔñÐÔÒÖÖÆÓÐÍû´ó´ó½µµÍ¶¾ÐÔ²¢ÌáÉýÁÆÐ§¡£IÆÚÊÔÑé°üÀ¨À©Õ¹½×¶ÎÔ¤¼ÆÕÐļԼ80Ãû»¼Õß £¬ÔÚÊÔÑéÖÐÒѾ­ÊӲ쵽3ÃûÁܰÍÁö»¼Õß¾­ÖÎÁƺ󼲲¡ÎȹÌ¡£µÚÈý¸ö¼ÁÁ¿£¨9 mg£©×éÒ»Àý¼±ÐÔËèϵ°×Ѫ²¡£¨AML£©»¼Õß¹ÇËèÖа×Ѫ²¡Ï¸°û±ÈÀý´Ó40%½µµÍÖÁ20%¡£

GFH009ÊÇwelcometo»¶Ó­¹âÁٱط¢¼¯ÍÅ×ÔÖ÷Ñз¢¡¢Ê׸ö×ÔÁ¦µÝ½»FDAÁÙ´²»ñÅúÏîÄ¿¡£CDK9µÄ»îÐÔÓë¶àÖÖÀàÐͰ©Ö¢»¼ÕßµÄ×ÜÉúÑÄÂÊ·ºÆð¸ºÏà¹Ø £¬µ«ÏÖÔÚÈ«ÇòÉÐÎÞ¸ßÑ¡ÔñÐÔCDK9ÒÖÖÆ¼Á»ñÅúÉÏÊÐ £¬GFH009Á¢Ïîʱ²¢Î´ÐγÉÁÙ´²ÑéÖ¤ £¬welcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÒ½Ò©¶­Ê³¤ÂÀÇ¿²©Ê¿ÌåÏÖÆäÑз¢Ï£ÍûÌåÏÖÁË¡°È«ÇòС±¿ª·¢ÀíÄî¡£¡°SELLASÔÚAMLºÍÆäËûѪҺÁö¡¢ÊµÌåÁöÁìÓòÓµÓÐרҵµÄÁÙ´²¿ª·¢ÄÜÁ¦ £¬½«×ÊÖú¿ìËÙÍÆ½øGFH009µÄÁÙ´²¿ª·¢ÒÔ¼°ÉÌÒµ»¯ £¬Ò²ÈÃÎÒÃǶԸòúÆ·×ßÏò¹ú¼ÊÊг¡¸üÓÐÐÅÐÄ¡£Ëæ×ÅÃ÷ÄêÎÒÃÇ»ùÓڸòúÆ·¿ªÕ¹¸ü¶àµÄÁÙ´²ÊÔÑé £¬GFH009Ò²½«ÓÐÍûÒÔ¸ü¿ìµÄËÙÂʻݼ°Öйú¼°È«Çò»¼Õß¡£¡°

SELLASÉúÃü¿ÆÑ§¼¯ÍÅCEO¼æ×ܲÃAngelos Stergious²©Ê¿ÌåÏÖGFH009¾ßÓгÉΪͬÀà×î¼Ñ²úÆ·µÄDZÁ¦£º¡°ÎÒÃÇÏàÐÅwelcometo»¶Ó­¹âÁٱط¢¼¯ÍŵÄÐÂÒ©Ñз¢Ð§Âʽ«Ê¹GFH009µÄÅäºÏ¿ª·¢ÖúÁ¦SELLAS £¬ÈÃÎÒÃÇÔÚδÀ´ÒÔÔ½·¢±¾Ç®¸ßЧµÄģʽ £¬Íƽø¸ü¶à˳Ӧ֢µÄÁÙ´²Ñо¿¡£ÎÒÃÇÔ¤¼ÆÓÚÃ÷ÄêÍ·Õë¶ÔAML»¼Õß¿ªÆôGFH009ÓëάÄÎÍпˣ¨venetoclax£©µÄÍŽáÁÆ·¨IIÆÚÊÔÑ飻¶øAMLÒàΪSELLAS¹ÜÏßÖÐÍ·²¿²úÆ·galinpepimut-S (¡°GPS¡±)µÄ˳Ӧ֢¡£±ðµÄ £¬ÎÒÃÇ»¹Õë¶Ô¶ùͯÈËȺÖи߶Èδ֪×ãµÄÒ½ÁÆÐèÇó £¬ÍýÏëÓÚ½ñÄêµ×»òÃ÷ÄêÍ·Õë¶Ô¶ùͯ»¼Õß¿ªÆôI/IIÆÚÀºÊ½ÊÔÑé¡£¡± 

GFH009ÔÚ¶àÖÖÈËÌåϸ°ûϵºÍ¼²²¡¶¯ÎïÄ£×ÓÖÐ £¬¿ÉÓÐÓÃÒÖÖÆ¶àÖÖÄ£×ÓÖ×ÁöÉú³¤ £¬¶ÔCDK9ÂѰ׵ÄÑ¡ÔñÐÔÒÖÖÆÂÊÁè¼ÝÆäËûCDKÑÇÐÍ100±¶ÒÔÉÏ¡£IIÆÚÊÔÑéÖÐGFH009½«ÓëvenetoclaxºÍazacitidineÁªÓÃÖÎÁÆAML»¼Õß £¬SELLASÉúÃü¿ÆÑ§¼¯ÍÅÏàÐÅGFH009ÓÐÍûÌáÉý»¼Õß¶ÔvenetoclaxµÄÓÃÒ©ÏìÓ¦ÂÊ¡£±ðµÄSELLAS»¹½«Õë¶Ô¶ùͯÈí×éÖ¯ÈâÁö£¨°üÀ¨ÓÈÒòÈâÁöºÍºáÎÆ¼¡ÈâÁö£©»¼Õß £¬¿ªÕ¹GFH009µ¥Ò©I/IIÆÚÀºÊ½ÊÔÑé £¬ÍýÏëÓÚ2023Äêµ×Íê³É¡£Í¬Ê± £¬welcometo»¶Ó­¹âÁٱط¢¼¯ÍÅÒ½Ò©ÍýÏëÔÚÖйúÕë¶ÔѪҺÁö¿ªÕ¹Ò»ÏµÁÐIIÆÚÁÙ´²ÊÔÑé¡£ 

ÍøÕ¾µØÍ¼